You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

CORPORATE

Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

The product is approved for post-exposure prophylaxis against rabies infection

read more 

EVENTS

Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

A crowded symposium dedicated to the SIPPET Study was held on July 9th

read more 
  1. CORPORATE - 30-04-2015

    Kedrion SpA’s Shareholders approve 2014 financial statement

    A 466 million euros’ turnover with a 9,8% rise on 2013

    read more 
  2. EVENTS - 17-04-2015

    Kedrion supported the XI World Hemophilia Day

    An increasingly tailor-made prophylaxis lets sports and hemorrhagic conditions live together

    read more 
  3. CORPORATE - 27-02-2015

    Kedrion unveils its new manufacturing plant in Castelvecchio Pascoli

    The company has invested over 67 million euros and is expected to create between 70 and 90 new jobs

    read more 

Pages

For more information please contact: pressoffice@kedrion.com